Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Go back to Immunotherapy Clinical Trials - A New Approach to Treating Cancer| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 3.52 +2.85 (425.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $9.09 | |||
| Open | $3.58 | 52 Week Low | $4.02 | |||
| Day High | $3.75 | P/E | N/A | |||
| Day Low | $3.10 | EPS | $-0.05 | |||
| Volume | 163,283 | |||||
